ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Apomorphine Hydrochloride Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-2C9445
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Apomorphine Hydrochloride Market Outlook 2022
BUY CHAPTERS

Global Apomorphine Hydrochloride Market Research Report 2024

Code: QYRE-Auto-2C9445
Report
January 2024
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
EVER Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion

Apomorphine Hydrochloride Market Size

The global Apomorphine Hydrochloride market was valued at US$ 277.7 million in 2023 and is anticipated to reach US$ 364.1 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.

Apomorphine Hydrochloride Market

Apomorphine Hydrochloride Market

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.
Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.
Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.
Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report aims to provide a comprehensive presentation of the global market for Apomorphine Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apomorphine Hydrochloride.

Report Scope

The Apomorphine Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Apomorphine Hydrochloride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Apomorphine Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Apomorphine Hydrochloride Market Report

Report Metric Details
Report Name Apomorphine Hydrochloride Market
Accounted market size in 2023 US$ 277.7 million
Forecasted market size in 2030 US$ 364.1 million
CAGR 3.9%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Injection
  • Tablets
  • Thinfilm
  • Nasal Powder (Pipeline)
Segment by Application
  • Parkinson Disease
  • Erectile Dysfunction
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma, Evolan Pharma AB (PharmSwed), Tianjin Tianwei Pharmaceutical, Sunovion
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Apomorphine Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Apomorphine Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Apomorphine Hydrochloride Market growing?

Ans: The Apomorphine Hydrochloride Market witnessing a CAGR of 3.9% during the forecast period 2024-2030.

What is the Apomorphine Hydrochloride Market size in 2030?

Ans: The Apomorphine Hydrochloride Market size in 2030 will be US$ 364.1 million.

What is the Apomorphine Hydrochloride Market share by application?

Ans: The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.

What is the Apomorphine Hydrochloride Market share by region?

Ans: Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019.

Who are the main players in the Apomorphine Hydrochloride Market report?

Ans: The main players in the Apomorphine Hydrochloride Market are Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma, Evolan Pharma AB (PharmSwed), Tianjin Tianwei Pharmaceutical, Sunovion

What are the Application segmentation covered in the Apomorphine Hydrochloride Market report?

Ans: The Applications covered in the Apomorphine Hydrochloride Market report are Parkinson Disease, Erectile Dysfunction

What are the Type segmentation covered in the Apomorphine Hydrochloride Market report?

Ans: The Types covered in the Apomorphine Hydrochloride Market report are Injection, Tablets, Thinfilm, Nasal Powder (Pipeline)

1 Apomorphine Hydrochloride Market Overview
1.1 Product Overview and Scope of Apomorphine Hydrochloride
1.2 Apomorphine Hydrochloride Segment by Type
1.2.1 Global Apomorphine Hydrochloride Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Tablets
1.2.4 Thinfilm
1.2.5 Nasal Powder (Pipeline)
1.3 Apomorphine Hydrochloride Segment by Application
1.3.1 Global Apomorphine Hydrochloride Market Value by Application: (2024-2030)
1.3.2 Parkinson Disease
1.3.3 Erectile Dysfunction
1.4 Global Apomorphine Hydrochloride Market Size Estimates and Forecasts
1.4.1 Global Apomorphine Hydrochloride Revenue 2019-2030
1.4.2 Global Apomorphine Hydrochloride Sales 2019-2030
1.4.3 Global Apomorphine Hydrochloride Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Apomorphine Hydrochloride Market Competition by Manufacturers
2.1 Global Apomorphine Hydrochloride Sales Market Share by Manufacturers (2019-2024)
2.2 Global Apomorphine Hydrochloride Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Apomorphine Hydrochloride Average Price by Manufacturers (2019-2024)
2.4 Global Apomorphine Hydrochloride Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Apomorphine Hydrochloride, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Apomorphine Hydrochloride, Product Type & Application
2.7 Apomorphine Hydrochloride Market Competitive Situation and Trends
2.7.1 Apomorphine Hydrochloride Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Apomorphine Hydrochloride Players Market Share by Revenue
2.7.3 Global Apomorphine Hydrochloride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Apomorphine Hydrochloride Retrospective Market Scenario by Region
3.1 Global Apomorphine Hydrochloride Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Apomorphine Hydrochloride Global Apomorphine Hydrochloride Sales by Region: 2019-2030
3.2.1 Global Apomorphine Hydrochloride Sales by Region: 2019-2024
3.2.2 Global Apomorphine Hydrochloride Sales by Region: 2025-2030
3.3 Global Apomorphine Hydrochloride Global Apomorphine Hydrochloride Revenue by Region: 2019-2030
3.3.1 Global Apomorphine Hydrochloride Revenue by Region: 2019-2024
3.3.2 Global Apomorphine Hydrochloride Revenue by Region: 2025-2030
3.4 North America Apomorphine Hydrochloride Market Facts & Figures by Country
3.4.1 North America Apomorphine Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Apomorphine Hydrochloride Sales by Country (2019-2030)
3.4.3 North America Apomorphine Hydrochloride Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Apomorphine Hydrochloride Market Facts & Figures by Country
3.5.1 Europe Apomorphine Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Apomorphine Hydrochloride Sales by Country (2019-2030)
3.5.3 Europe Apomorphine Hydrochloride Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Apomorphine Hydrochloride Market Facts & Figures by Country
3.6.1 Asia Pacific Apomorphine Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Apomorphine Hydrochloride Sales by Country (2019-2030)
3.6.3 Asia Pacific Apomorphine Hydrochloride Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Apomorphine Hydrochloride Market Facts & Figures by Country
3.7.1 Latin America Apomorphine Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Apomorphine Hydrochloride Sales by Country (2019-2030)
3.7.3 Latin America Apomorphine Hydrochloride Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Apomorphine Hydrochloride Market Facts & Figures by Country
3.8.1 Middle East and Africa Apomorphine Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Apomorphine Hydrochloride Sales by Country (2019-2030)
3.8.3 Middle East and Africa Apomorphine Hydrochloride Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Apomorphine Hydrochloride Sales by Type (2019-2030)
4.1.1 Global Apomorphine Hydrochloride Sales by Type (2019-2024)
4.1.2 Global Apomorphine Hydrochloride Sales by Type (2025-2030)
4.1.3 Global Apomorphine Hydrochloride Sales Market Share by Type (2019-2030)
4.2 Global Apomorphine Hydrochloride Revenue by Type (2019-2030)
4.2.1 Global Apomorphine Hydrochloride Revenue by Type (2019-2024)
4.2.2 Global Apomorphine Hydrochloride Revenue by Type (2025-2030)
4.2.3 Global Apomorphine Hydrochloride Revenue Market Share by Type (2019-2030)
4.3 Global Apomorphine Hydrochloride Price by Type (2019-2030)
5 Segment by Application
5.1 Global Apomorphine Hydrochloride Sales by Application (2019-2030)
5.1.1 Global Apomorphine Hydrochloride Sales by Application (2019-2024)
5.1.2 Global Apomorphine Hydrochloride Sales by Application (2025-2030)
5.1.3 Global Apomorphine Hydrochloride Sales Market Share by Application (2019-2030)
5.2 Global Apomorphine Hydrochloride Revenue by Application (2019-2030)
5.2.1 Global Apomorphine Hydrochloride Revenue by Application (2019-2024)
5.2.2 Global Apomorphine Hydrochloride Revenue by Application (2025-2030)
5.2.3 Global Apomorphine Hydrochloride Revenue Market Share by Application (2019-2030)
5.3 Global Apomorphine Hydrochloride Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Supernus Pharmaceuticals
6.1.1 Supernus Pharmaceuticals Corporation Information
6.1.2 Supernus Pharmaceuticals Description and Business Overview
6.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolio
6.1.5 Supernus Pharmaceuticals Recent Developments/Updates
6.2 Britannia Pharmaceuticals STADA
6.2.1 Britannia Pharmaceuticals STADA Corporation Information
6.2.2 Britannia Pharmaceuticals STADA Description and Business Overview
6.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolio
6.2.5 Britannia Pharmaceuticals STADA Recent Developments/Updates
6.3 Ever Pharma
6.3.1 Ever Pharma Corporation Information
6.3.2 Ever Pharma Description and Business Overview
6.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ever Pharma Apomorphine Hydrochloride Product Portfolio
6.3.5 Ever Pharma Recent Developments/Updates
6.4 Evolan Pharma AB (PharmSwed)
6.4.1 Evolan Pharma AB (PharmSwed) Corporation Information
6.4.2 Evolan Pharma AB (PharmSwed) Description and Business Overview
6.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolio
6.4.5 Evolan Pharma AB (PharmSwed) Recent Developments/Updates
6.5 Tianjin Tianwei Pharmaceutical
6.5.1 Tianjin Tianwei Pharmaceutical Corporation Information
6.5.2 Tianjin Tianwei Pharmaceutical Description and Business Overview
6.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolio
6.5.5 Tianjin Tianwei Pharmaceutical Recent Developments/Updates
6.6 Sunovion
6.6.1 Sunovion Corporation Information
6.6.2 Sunovion Description and Business Overview
6.6.3 Sunovion Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sunovion Apomorphine Hydrochloride Product Portfolio
6.6.5 Sunovion Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Apomorphine Hydrochloride Industry Chain Analysis
7.2 Apomorphine Hydrochloride Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Apomorphine Hydrochloride Production Mode & Process
7.4 Apomorphine Hydrochloride Sales and Marketing
7.4.1 Apomorphine Hydrochloride Sales Channels
7.4.2 Apomorphine Hydrochloride Distributors
7.5 Apomorphine Hydrochloride Customers
8 Apomorphine Hydrochloride Market Dynamics
8.1 Apomorphine Hydrochloride Industry Trends
8.2 Apomorphine Hydrochloride Market Drivers
8.3 Apomorphine Hydrochloride Market Challenges
8.4 Apomorphine Hydrochloride Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
EVER Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion
List of Tables
    Table 1. Global Apomorphine Hydrochloride Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Apomorphine Hydrochloride Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Apomorphine Hydrochloride Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Apomorphine Hydrochloride Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Apomorphine Hydrochloride Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Apomorphine Hydrochloride Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Apomorphine Hydrochloride Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Apomorphine Hydrochloride Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Apomorphine Hydrochloride, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Apomorphine Hydrochloride, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Apomorphine Hydrochloride, Product Type & Application
    Table 12. Global Key Manufacturers of Apomorphine Hydrochloride, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Apomorphine Hydrochloride by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Apomorphine Hydrochloride as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Apomorphine Hydrochloride Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Apomorphine Hydrochloride Sales by Region (2019-2024) & (K Units)
    Table 18. Global Apomorphine Hydrochloride Sales Market Share by Region (2019-2024)
    Table 19. Global Apomorphine Hydrochloride Sales by Region (2025-2030) & (K Units)
    Table 20. Global Apomorphine Hydrochloride Sales Market Share by Region (2025-2030)
    Table 21. Global Apomorphine Hydrochloride Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Apomorphine Hydrochloride Revenue Market Share by Region (2019-2024)
    Table 23. Global Apomorphine Hydrochloride Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Apomorphine Hydrochloride Revenue Market Share by Region (2025-2030)
    Table 25. North America Apomorphine Hydrochloride Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Apomorphine Hydrochloride Sales by Country (2019-2024) & (K Units)
    Table 27. North America Apomorphine Hydrochloride Sales by Country (2025-2030) & (K Units)
    Table 28. North America Apomorphine Hydrochloride Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Apomorphine Hydrochloride Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Apomorphine Hydrochloride Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Apomorphine Hydrochloride Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Apomorphine Hydrochloride Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Apomorphine Hydrochloride Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Apomorphine Hydrochloride Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Apomorphine Hydrochloride Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Apomorphine Hydrochloride Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Apomorphine Hydrochloride Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Apomorphine Hydrochloride Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Apomorphine Hydrochloride Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Apomorphine Hydrochloride Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Apomorphine Hydrochloride Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Apomorphine Hydrochloride Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Apomorphine Hydrochloride Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Apomorphine Hydrochloride Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Apomorphine Hydrochloride Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Apomorphine Hydrochloride Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Apomorphine Hydrochloride Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Apomorphine Hydrochloride Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Apomorphine Hydrochloride Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Apomorphine Hydrochloride Sales (K Units) by Type (2019-2024)
    Table 51. Global Apomorphine Hydrochloride Sales (K Units) by Type (2025-2030)
    Table 52. Global Apomorphine Hydrochloride Sales Market Share by Type (2019-2024)
    Table 53. Global Apomorphine Hydrochloride Sales Market Share by Type (2025-2030)
    Table 54. Global Apomorphine Hydrochloride Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Apomorphine Hydrochloride Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Apomorphine Hydrochloride Revenue Market Share by Type (2019-2024)
    Table 57. Global Apomorphine Hydrochloride Revenue Market Share by Type (2025-2030)
    Table 58. Global Apomorphine Hydrochloride Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Apomorphine Hydrochloride Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Apomorphine Hydrochloride Sales (K Units) by Application (2019-2024)
    Table 61. Global Apomorphine Hydrochloride Sales (K Units) by Application (2025-2030)
    Table 62. Global Apomorphine Hydrochloride Sales Market Share by Application (2019-2024)
    Table 63. Global Apomorphine Hydrochloride Sales Market Share by Application (2025-2030)
    Table 64. Global Apomorphine Hydrochloride Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Apomorphine Hydrochloride Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Apomorphine Hydrochloride Revenue Market Share by Application (2019-2024)
    Table 67. Global Apomorphine Hydrochloride Revenue Market Share by Application (2025-2030)
    Table 68. Global Apomorphine Hydrochloride Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Apomorphine Hydrochloride Price (USD/Unit) by Application (2025-2030)
    Table 70. Supernus Pharmaceuticals Corporation Information
    Table 71. Supernus Pharmaceuticals Description and Business Overview
    Table 72. Supernus Pharmaceuticals Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Supernus Pharmaceuticals Apomorphine Hydrochloride Product
    Table 74. Supernus Pharmaceuticals Recent Developments/Updates
    Table 75. Britannia Pharmaceuticals STADA Corporation Information
    Table 76. Britannia Pharmaceuticals STADA Description and Business Overview
    Table 77. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product
    Table 79. Britannia Pharmaceuticals STADA Recent Developments/Updates
    Table 80. Ever Pharma Corporation Information
    Table 81. Ever Pharma Description and Business Overview
    Table 82. Ever Pharma Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Ever Pharma Apomorphine Hydrochloride Product
    Table 84. Ever Pharma Recent Developments/Updates
    Table 85. Evolan Pharma AB (PharmSwed) Corporation Information
    Table 86. Evolan Pharma AB (PharmSwed) Description and Business Overview
    Table 87. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product
    Table 89. Evolan Pharma AB (PharmSwed) Recent Developments/Updates
    Table 90. Tianjin Tianwei Pharmaceutical Corporation Information
    Table 91. Tianjin Tianwei Pharmaceutical Description and Business Overview
    Table 92. Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product
    Table 94. Tianjin Tianwei Pharmaceutical Recent Developments/Updates
    Table 95. Sunovion Corporation Information
    Table 96. Sunovion Description and Business Overview
    Table 97. Sunovion Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Sunovion Apomorphine Hydrochloride Product
    Table 99. Sunovion Recent Developments/Updates
    Table 100. Key Raw Materials Lists
    Table 101. Raw Materials Key Suppliers Lists
    Table 102. Apomorphine Hydrochloride Distributors List
    Table 103. Apomorphine Hydrochloride Customers List
    Table 104. Apomorphine Hydrochloride Market Trends
    Table 105. Apomorphine Hydrochloride Market Drivers
    Table 106. Apomorphine Hydrochloride Market Challenges
    Table 107. Apomorphine Hydrochloride Market Restraints
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Apomorphine Hydrochloride
    Figure 2. Global Apomorphine Hydrochloride Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Apomorphine Hydrochloride Market Share by Type in 2023 & 2030
    Figure 4. Injection Product Picture
    Figure 5. Tablets Product Picture
    Figure 6. Thinfilm Product Picture
    Figure 7. Nasal Powder (Pipeline) Product Picture
    Figure 8. Global Apomorphine Hydrochloride Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Apomorphine Hydrochloride Market Share by Application in 2023 & 2030
    Figure 10. Parkinson Disease
    Figure 11. Erectile Dysfunction
    Figure 12. Global Apomorphine Hydrochloride Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Apomorphine Hydrochloride Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Apomorphine Hydrochloride Sales (2019-2030) & (K Units)
    Figure 15. Global Apomorphine Hydrochloride Average Price (USD/Unit) & (2019-2030)
    Figure 16. Apomorphine Hydrochloride Report Years Considered
    Figure 17. Apomorphine Hydrochloride Sales Share by Manufacturers in 2023
    Figure 18. Global Apomorphine Hydrochloride Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Apomorphine Hydrochloride Players: Market Share by Revenue in 2023
    Figure 20. Apomorphine Hydrochloride Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Apomorphine Hydrochloride Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Apomorphine Hydrochloride Sales Market Share by Country (2019-2030)
    Figure 23. North America Apomorphine Hydrochloride Revenue Market Share by Country (2019-2030)
    Figure 24. U.S. Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Apomorphine Hydrochloride Sales Market Share by Country (2019-2030)
    Figure 27. Europe Apomorphine Hydrochloride Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Apomorphine Hydrochloride Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Apomorphine Hydrochloride Revenue Market Share by Region (2019-2030)
    Figure 35. China Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Taiwan Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Indonesia Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Thailand Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Malaysia Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Philippines Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Apomorphine Hydrochloride Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Apomorphine Hydrochloride Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Apomorphine Hydrochloride Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Apomorphine Hydrochloride Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. UAE Apomorphine Hydrochloride Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Apomorphine Hydrochloride by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Apomorphine Hydrochloride by Type (2019-2030)
    Figure 57. Global Apomorphine Hydrochloride Price (USD/Unit) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Apomorphine Hydrochloride by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Apomorphine Hydrochloride by Application (2019-2030)
    Figure 60. Global Apomorphine Hydrochloride Price (USD/Unit) by Application (2019-2030)
    Figure 61. Apomorphine Hydrochloride Value Chain
    Figure 62. Apomorphine Hydrochloride Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions